FRANKLIN, Tenn.--(BUSINESS WIRE)--BioMimetic Therapeutics, Inc. (NASDAQ: BMTI) announced today that Dr. Samuel E. Lynch, president and CEO, will provide an update of corporate activities at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference. The presentation will take place in the Kennedy II Room of the New York Palace Hotel in New York City on Wednesday, November 7 at 9:10 a.m. Eastern Time.
